Suchergebnisse - "Rodríguez-Baño, Jesús"

PubPharm (10)

1

Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO) : an international, open-label, parallel-group, randomised, controlled, non-inferiority trial

enthalten in: The Lancet. Infectious diseases | 2024

von Kaasch, A. | López-Cortés, L. | Rodríguez-Baño, J. | +64

2

Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY) : an open-label, multicentre, randomised trial

enthalten in: The Lancet. Infectious diseases | 2024

von López-Cortés, L. | Delgado-Valverde, M. | Moreno-Mellado, E. | +65

3

Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli : a post hoc analysis of the FOREST randomized trial

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Sojo-Dorado, J. | López-Hernández, I. | Hernández-Torres, A. | +24

4

Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers

enthalten in: The New England journal of medicine | 2023

von Pittet, L. | Messina, N. | Orsini, F. | +142

CommentIn: N Engl J Med. 2023 Jul 13;389(2):191. - PMID 37437154

5

Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales : a randomized, controlled trial

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Molina, J. | Montero-Mateos, E. | Praena-Segovia, J. | +38

CommentIn: Clin Microbiol Infect. 2022 Apr;28(4):463-464. - PMID 34823011

6

Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients With Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy : A Case Report of Two Cases

enthalten in: Frontiers in immunology | 2022

von Martínez-Chinchilla, C. | Vazquez-Montero, L. | Palazón-Carrión, N. | +5

7

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections : A Randomized Clinical Trial

enthalten in: JAMA network open | 2022

von Sojo-Dorado, J. | López-Hernández, I. | Rosso-Fernandez, C. | +79

CommentIn: JAMA Netw Open. 2022 Jan 4;5(1):e2138691. - PMID 35024841

8

Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY) : a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferiority clinical trial

enthalten in: BMJ open | 2017

von López-Cortés, L. | Rosso-Fernández, C. | Núñez-Núñez, M. | +8

9

Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO) : study protocol for a randomized controlled trial

enthalten in: Trials | 2015

von Kaasch, A. | Fätkenheuer, G. | Prinz-Langenohl, R. | +60

10

Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST) : study protocol for an investigator-driven randomised controlled trial

enthalten in: BMJ open | 2015

von Rosso-Fernández, C. | Sojo-Dorado, J. | Barriga, A. | +30

1
[1]